Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Medications for Acute Lymphoblastic Leukemia

About Acute Lymphoblastic Leukemia:  Cancer of a specific type of white blood cell called lymphocytes.

Drugs Used to Treat Acute Lymphoblastic Leukemia

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
methotrexate X N X Add review Rate

Generic name: methotrexate systemic

Brand names:  Trexall, Xatmep

Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Gleevec D N 1 review
10

Generic name: imatinib systemic

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

mercaptopurine D N Add review Rate

Generic name: mercaptopurine systemic

Brand names:  Purinethol, Purixan

Drug class: antimetabolites

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Sprycel D N 1 review
10

Generic name: dasatinib systemic

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

dasatinib D N 1 review
10

Generic name: dasatinib systemic

Brand name:  Sprycel

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Adriamycin D N Add review Rate

Generic name: doxorubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Trexall X N X Add review Rate

Generic name: methotrexate systemic

Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Iclusig D N 1 review
1.0

Generic name: ponatinib systemic

Drug class: multikinase inhibitors, BCR-ABL tyrosine kinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Blincyto C N Add review Rate

Generic name: blinatumomab systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

pegaspargase C N Add review Rate

Generic name: pegaspargase systemic

Brand name:  Oncaspar

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

doxorubicin D N Add review Rate

Generic name: doxorubicin systemic

Brand name:  Adriamycin

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

imatinib D N 1 review
10

Generic name: imatinib systemic

Brand name:  Gleevec

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Oncaspar C N Add review Rate

Generic name: pegaspargase systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Purinethol D N Add review Rate

Generic name: mercaptopurine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Erwinaze C N Add review Rate

Generic name: asparaginase erwinia chrysanthemi systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

ponatinib D N 1 review
1.0

Generic name: ponatinib systemic

Brand name:  Iclusig

Drug class: multikinase inhibitors, BCR-ABL tyrosine kinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

blinatumomab C N Add review Rate

Generic name: blinatumomab systemic

Brand name:  Blincyto

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

vincristine liposome D N Add review Rate

Generic name: vincristine liposome systemic

Brand name:  Marqibo

Drug class: mitotic inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts

asparaginase erwinia chrysanthemi C N Add review Rate

Generic name: asparaginase erwinia chrysanthemi systemic

Brand name:  Erwinaze

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Marqibo D N Add review Rate

Generic name: vincristine liposome systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

Vumon D N Add review Rate

Generic name: teniposide systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Xatmep X N X Add review Rate

Generic name: methotrexate systemic

Drug class: antimetabolites, antirheumatics, other immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Arranon D N Add review Rate

Generic name: nelarabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Besponsa N Add review Rate

Generic name: inotuzumab ozogamicin systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Clolar D N X Add review Rate

Generic name: clofarabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Page 1 2

Learn more about Acute Lymphoblastic Leukemia

Micromedex® Care Notes

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide